Mesoeye C71 – Undereye Bags Solution

Description

Mesoeye C71 is an elite, biocompatible injectable treatment engineered specifically to treat the fragile periocular (eye contour) zone. Developed by ABG Lab (USA), this advanced mesotherapy formulation treats undereye puffiness, dark circles, drooping eyelids, and deep crow’s feet. Rather than functioning as a standard dermal filler that simply cloaks lines, Mesoeye C71 works at a structural and vascular level. It combines patented peptide technologies with non-crosslinked hyaluronic acid to repair local microcirculation, eliminate fluid retention, and rebuild the thinned dermal matrix under the eyes.

Main Benefits of Mesoeye C71

• Vascular Micro-Circulation Repair: Patented peptides restore healthy blood flow and strengthen weak capillary walls, targeting the root cause of dark circles.

• Rapid Lymphatic Drainage: Actively reduces capillary permeability and drives fluid clearance to drain stubborn undereye bags and puffiness.

• Structural Collagen Synthesis: Triggers the birth of fresh collagen and elastin fibers, tightening thin, crepey under-eye skin.

• Intense Cellular Hydration: High-purity, non-crosslinked Hyaluronic Acid smooths fine dehydration lines and plumps structural hollows.

• Anti-Inflammatory Protection: Guards vulnerable eye tissue from oxidative stress, maintaining a bright, well-rested appearance.

Indications

Mesoeye C71 is indicated for direct micro-injection into the upper and lower eyelids to correct aging and structural changes:

• Undereye Bags & Chronic Puffiness: Eliminating localized fluid pockets and treating loose fat herniation.

• Dark Circles & Vascular Discoloration: Brightening dark shadows caused by poor blood flow and thin, translucent skin.

• Periorbital Wrinkles (Crow’s Feet): Smoothing fine lines, smile creases, and dynamic dehydration folds around the temples.

• Upper Eyelid Ptosis: Firming skin tissue to lift slightly drooping or hooded upper eyelids.

• Loss of Skin Elasticity: Re-densifying fragile, paper-thin skin matrix beneath the eye contours.

Technical Specifications

Feature	Specification
Product Name	Mesoeye C71
Manufacturer	ABG Lab (USA)
Active Ingredients	PeriOrbital Peptide XP2™, Hexapeptide-17, Non-crosslinked HA
HA Concentration	0.4% High-molecular-weight Hyaluronic Acid
Core Co-Factors	Over 50 Vitamins, Amino Acids, and Trace Minerals
Category	Mesotherapy / Periocular Biorevitalizer
Packaging	1 x 1ml Pre-filled syringe per box
Application Layer	Superficial dermis / Subcutaneous fat layer (Periocular)
Treatment Interval	3 to 6 sessions spaced 10 to 14 days apart
Storage	Store between 2°C to 25°C; protect from freezing

Mechanism of Action

The formulation operates through Vascular and Cellular Biomodulation:

1. PeriOrbital Peptide XP2™ Activation: This proprietary peptide removes localized arterial spasms and reduces the leakage of fluid from small blood vessels, stopping puffiness from gathering.

2. Hexapeptide-17 Lymphatic Drainage: Stimulates lymphatic receptors to quickly drain excess fluid, clearing toxic waste products and reducing under-eye bags.

3. Hydro-Dermal Integration: Pure, non-crosslinked HA anchors water molecules within the thinned intercellular space, softening rough, crepey lines instantly.

4. Dermal Matrix Re-Thickening: The rich vitamin, mineral, and amino acid co-factors feed native fibroblasts, encouraging them to spin out a fresh network of young collagen.

Administration Protocol

• Technique: Administered exclusively by a trained professional utilizing the micro-papule technique or specialized infiltration depending on whether the target is surface lines or deep fluid pockets.

• Injection Tool: Delivered using ultra-fine sterile needles (typically 32G or 33G, 4mm length) to maximize safety and patient comfort.

• Injection Depth: Placed into the superficial dermis for surface lines, or slightly deeper into the subcutaneous fat pads when treating fluid bags. Injection directly into the eyeball or bony structures must be strictly avoided.

• Treatment Cycle: An optimal corrective protocol consists of 3 to 6 sessions, spaced precisely 10 to 14 days apart. Maintenance sessions can be performed every 6 months.

• Post-Treatment Guidelines: Small micro-papules and mild localized swelling are standard, healthy reactions that fade within 24 to 72 hours. Patients must skip eye makeup for 12 hours, avoid rubbing the eyes, and stay away from saunas, steam rooms, and intense gym sessions for 48 hours.

FAQ

Q: Is Mesoeye C71 an undereye filler?

A: No. Standard dermal fillers use cross-linked HA to build volume and fill dark hollows. Mesoeye C71 uses non-crosslinked HA mixed with active peptides to heal blood vessels, drain fluid retention, and tighten skin. It does not swell up or draw excessive water, making it safe for patients prone to morning eye puffiness.

Q: Can this treatment fix dark circles caused by deep bone structure?

A: Mesoeye C71 is excellent for treating dark circles caused by thin skin, poor blood flow, and hyperpigmentation. If dark circles are purely caused by deep bone structures casting a physical shadow, it can be combined with soft HA fillers to lift the hollow space.

Q: How soon will the patient notice a change?

A: A noticeable drop in morning eye puffiness and improved hydration often appears within 3 to 5 days after the first session. The progressive clearing of dark circles and tightening of crepey skin maximize over the full treatment course.

IMPORTANT NOTICE ON INTELLECTUAL PROPERTY

This store operates as an autonomous merchant of genuine medical aesthetic products. We maintain no formal affiliation, partnership, or authorized distribution agreement with ABG Lab or its global subsidiaries. All proprietary names, logos, and trademarks mentioned herein remain the exclusive intellectual property of their rightful owners. Their use on this site is strictly for the identification and description of the original goods we provide as an independent reseller.